Zepbound (tirzepatide) is an FDA-approved prescription medication indicated for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition, such as hypertension, type 2 diabetes, or dyslipidemia
This news is one step in the direction of increasing access to these effective treatments for obesity
Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action
When earlier this year, the Health Justice Initiative took legal action to force the Department of Health to disclose secret contracts with Covid-19 vaccine manufacturers, we won and the documents revealed that vaccine procurement negotiations were one-sided, with pharmaceutical companies pressuring our government into unfair prices, terms and conditions
Diabetes Care 30:12121218 Grygiel-Grniak B (2014) Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications a review
FDA-approved GLP-1 drugs like Wegovy are explicitly cleared for weight loss in people with a BMI over 30 and for those with a BMI below 27 who have weight-related comorbidities like diabetes, hypertension, high cholesterol, and sleep apnea
